All posts by imreal

Firefly Autism Now Offers Diagnostic Testing for Individuals Aged 18 Months to 99+ Who Are Experiencing a Variety of Developmental, Behavioral, and Learning Differences


Dr. McVey and the staff at Firefly Autism walked us through the process and answered our many questions along the way. Our son’s diagnosis was delivered with care, compassion and empowerment – we finally had a path forward.

Firefly Autism now offers diagnostics testing and evaluation for individuals experiencing a variety of developmental, behavioral, and learning differences. Led by Dr. Rebecca McVey, Firefly’s Diagnostics & Behavioral Health Services specializes in psychological testing for toddlers, children, adolescents, and adults.

“I feel that every child and adult deserves access to not only comprehensive, data driven, and research-based assessment and treatment, but most importantly to compassion and empathy throughout the client’s journey,” says Dr. McVey.

The Firefly team is dedicated to providing compassionate care and personalized service. In order to provide the best possible care for each individual patient, they utilize a multidisciplinary team approach. This means that each patient will have a team of specialists working together to address their specific needs. This team approach allows for a more comprehensive treatment plan that is tailored to the individual’s unique needs.

“Quite frankly, we were in over our heads – we knew our son was struggling and knew there was “more than meets the eye” on how to help him. After years of awareness, advocacy and education that we were exposed to from Firefly Autism, we decided to have our son go through the diagnostic process. Other organizations offered to place us on their waitlists which ranged from 12 to 20 months until appointments were available. Firefly got us in within a few weeks,” comments one Firefly parent.

“Dr. McVey and the staff at Firefly Autism walked us through the process and answered our many questions along the way. Our son’s diagnosis was delivered with care, compassion and empowerment – we finally had a path forward. Dr. McVey has remained available and actively assisted as an advocate for our child with his educational plans at school. We will be eternally grateful for the support from Firefly Autism.”

Firefly Autism’s goal is aimed at helping its patients reach their fullest potential. Utilizing data from standardized diagnostic tools along with collateral information from relevant stakeholders, including parents, educators, doctors, and therapists, Firefly Diagnostics & Behavioral Health Services offers the ability to assess a variety of cognitive, behavioral, and social-emotional domains to best understand an individual’s strengths and weaknesses.

Scheduling a diagnostics appointment can be done here or by reaching out to Firefly’s Intake & Scheduling Coordinator, Suzanne Fewer, at sfewer@fireflyautism.org. Firefly accepts Kaiser health insurance and private pay options for diagnostic testing.

Firefly Autism is open to donations for diagnostic testing; each test costs $2,500 to conduct. Funds raised from Colorado Gives Day directly goes to paying for autism diagnostic tests for individuals in the community. Every donation made now through December 6, 2022 gets a boost from Colorado Gives $1.4 Million+ Incentive Fund. Visit http://www.coloradogives.org to donate.

To learn more about Firefly Autism Diagnostics & Behavioral Health Services, please visit http://www.fireflyautism.org or contact Nicole Abunassar at nicole@nkgroupe.com.

About Dr. Rebecca McVey

Dr. McVey is a Postdoctoral Psychologist Candidate, a Nationally Certified School Psychologist and a Board-Certified Behavior Analyst with over 10 years of experience serving individuals with a variety of neurodevelopmental disabilities. Dr. McVey has done work across settings including schools, home-based, clinics, private practices, hospitals, and community-based work. With such a broad range of experience, Dr. McVey utilizes a wholistic approach to assessment and treatment and always uses data from across settings to make clinical decisions. Personal autonomy, and self-determination are at heart of all that she does as a clinician and client empowerment and celebration of neurodiversity are at the core of her professional philosophy.

Share article on social media or email:

Upswing Health Appoints Roy Sailor as Chief Growth Officer


News Image

Upswing Health, the physician-founded musculoskeletal (MSK) healthcare innovator, today announced the appointment of Roy Sailor as Chief Growth Officer. An experienced healthcare technology leader, Sailor will assume management for driving Upswing’s continued growth, collaborating with the company’s executive team to expand strategic partnerships while scaling the company’s service, product line and sales teams.

“Roy has been a valued advisor for Upswing Health since our early days, sharing his decades of healthcare leadership and experience,” said Yenvy Truong, Upswing Health’s CEO. “We are excited to have him formally join as we enter our next phase of growth and pursue our mission to help millions eliminate suffering associated with joint and muscle pain.”

Roy brings more than 30 years of healthcare leadership experience in operational, technology, business development and sales roles. He possesses a strong track record of exceeding business, client and financial objectives for high-growth, high-intensity companies. Throughout his career, Roy has held senior leadership and business development positions across a range of leading healthcare companies, including UnitedHealth Group’s Optum, Computer Sciences Corp, Perot Systems, First Consulting Group and EDS.

“From the beginning, I have been a strong supporter of Upswing Health’s mission to transform healthcare by addressing the significant challenges in MSK care today,” said Sailor. “I am excited to join the company’s talented management team and look forward to working together to spearhead and accelerate growth.”

About Upswing Health:

Upswing Health is a startup that was created to solve the waste and inefficiency of America’s multi-billion-dollar crisis in MSK care with a radical re-reinvention of the delivery system – for individuals and employers. The company replaces the current model, which forces the injured to struggle through the time-consuming and costly choices of ERs, Urgent Care Centers, Primary Care Physicians, and Orthopedists. USH’s digital platform replaces that broken system with a better way using a proprietary diagnostic tool that sends patients to a health coach first as the virtual front-door to MSK care. This is sufficient for as many as 80% of all cases; those who need more sophisticated care are rapidly triaged. Patients stay in the USH ecosystem for the entirety of their journey– from prevention to diagnosis and recovery. USH was founded by orthopedic surgeons and is already working for a state government and municipality health plans and major healthcare providers. For more information on Upswing Health, please visit: http://www.UpswingHealth.com.

Share article on social media or email:

RevSpring Announces Conversations™ to Advance Patient Interactions and Engagement


“Enabling patients to dialog with providers using the device in their hand—anytime, anywhere—will help RevSpring customers bolster patient engagement while increasing satisfaction and loyalty.”

RevSpring, the leading provider of healthcare engagement and payment solutions, today announced a new patient communications solution enabling bi-directional communication between patients and office staff and/or an automated agent. Conversations increases options for personal or automated communication to significantly reduce office call volume and improve patient engagement through OmniChannel communication access.

Conversations orchestrates incoming patient messages through a staff-facing messaging center, making it easier for healthcare providers to manage a higher number of patient interactions. Conversations can seamlessly transition from bot-led to staff-assisted interactions, allowing providers to maintain a balance between automation and hands-on personalization.

“We’re thrilled to introduce Conversations to the market to augment our suite of OmniChannel communication engagement tools with bi-directional capabilities,” said Howard Bright, CTO of patient engagement and analytics at RevSpring. “Enabling patients to dialog with providers using the device in their hand—anytime, anywhere—will help RevSpring customers bolster patient engagement while increasing satisfaction and loyalty.”

Research confirms that people prefer texting, with 78% of people expressing the wish to have a text conversation with the businesses with whom they interact. Conversations increases texting ease by routing incoming text messages through a messaging management tool. Staff are empowered to facilitate timely conversations and provide valuable resources to the patient using templated or ad hoc messages. Magic links connect patients to personalized actions in a few clicks, such as completing a check-in form or making a copayment. Message assignment can also be coordinated between staff and departments as needed.

Built on RevSpring’s leading Talksoft® platform, Conversations is seamlessly integrated across RevSpring’s solution set from preservice to payment, including appointment reminders, virtual check-in, and patient messaging. Conversations allows providers to send and exchange text messages across these applications from a consistent, trusted phone number, which becomes a valuable brand asset in other patient outreach.

“By leveraging the organization’s phone number for multiple communication options for the patient, messages will be more recognized, connected and trusted, which greatly increases the likelihood that patients will take desired actions,” added Bright.

The solution also eases staff demand by embedding artificial intelligence that enables Conversation bots to recognize intent, context and phrase variation common in natural human language. It can be used for a variety of use cases, including facilitating reschedule requests.

Conversations also helps reduce compliance risk associated with maintaining multiple SMS vendors by centralizing management of opt-out lists. In addition, patients can be automatically informed about HIPAA terms and acceptance before a dialogue occurs. Conversations saves this information in the patient’s messaging history to ensure proper documentation. With Conversations, both patients and healthcare staff experience communication that is secure, efficient and convenient.

About RevSpring

RevSpring leads the market in patient engagement and payment solutions that inspire patients to participate in and pay for their healthcare. The company has built the industry’s most comprehensive and impactful suite of patient engagement, OmniChannel communications and payment solutions backed by behavior analysis, propensity-to-pay scoring, contextual messaging, and user experience best practices. Using proprietary data analytics to tailor the engagement from preservice to post-service, RevSpring improves the patient experience and outcomes for providers and their patients. To learn more, visit revspringinc.com/healthcare.

Share article on social media or email:

XProtect Rapid REVIEW Wins 2022 Video Analytics Product of the Year Award


News Image

With XProtect Rapid REVIEW, system users get an advanced forensic video analytics add-on that enables them to quickly review and analyze video content and find what they’re looking for fast, said Tim Palmquist, VP, Americas, Milestone Systems.

Milestone Systems is pleased to announce that its industry-leading XProtect Rapid REVIEW VMS extension has won the Video Analytics category for the Security Today 2022 New Product Awards! The Security Today New Product of the Year program honors the outstanding product development achievements of security technology and solutions manufacturers whose products are considered particularly noteworthy in their ability to improve security.

Driven to provide real-world technology solutions to help video security users meet their daily and long-term video data needs, Milestone Systems partnered with BriefCam to offer a completely integrated video analytics solution within XProtect, the industry’s leading open platform Video Management Software (VMS).

Video footage often captures incidents that need to be examined, including missing persons, vandalism, thefts, assaults, accidents, workplace injuries or harassment claims. XProtect Rapid REVIEW enables fast and intelligent multi-camera searches based on an expanding suite of analytic search filters, allowing users to quickly find the evidence and information they need. The patented VIDEO SYNOPSIS® capability simultaneously displays objects that have appeared at different times within the video, making investigations faster and more efficient than ever.

“With XProtect Rapid REVIEW, system users get an advanced forensic video analytics add-on that enables them to quickly review and analyze video content and find what they’re looking for fast,” said Tim Palmquist, VP, Americas, Milestone Systems. “Where it previously may have taken days or weeks to review several thousands of hours of recorded video from hundreds of cameras, with Rapid REVIEW, it can all be done in a matter of minutes or hours.”

Powered by the innovative BriefCam video analytics technology, XProtect Rapid REVIEW is an add-on product that integrates seamlessly into Milestone’s XProtect Smart Client, is supported on all paid XProtect VMS products, and is now available through Milestone-certified partners.

Unlock the Value of Video

Rapid REVIEW helps security professionals take their video system beyond security with the ability to analyze object activity, common paths, and dwell times. With easy-to-read visualizations with the graphic layers included, XProtect Rapid REVIEW gives users the power to forensically pinpoint the areas with the most occupancies for greater scene understanding and insights.

For example, retail store management can identify customer occupancies through the store and understand how customers navigate their stores to ensure better product placement, staffing and a superior customer experience.

Click here for more information about XProtect Rapid REVIEW.

    Resources

  • Click HERE to learn more about how Milestone’s video technology helps create safer hospital environments.
  • Download Milestone Systems logos HERE.

About Milestone Systems

Milestone Systems is a leading provider of data-driven video technology software in and beyond security that helps the world see how to ensure safety, protect assets, and increase business efficiency. Milestone enables an open platform community that drives collaboration and innovation in the development and use of network video technology, with reliable and scalable solutions that are proven in more than 500,000 customer sites worldwide. Founded in 1998, Milestone is a stand-alone company in the Canon Group. For more information visit: http://www.milestonesys.com

Company Contact:

Barbara Rizzatti

Communications Manager

AMERICAS

bari@milestone.us

Tel: 503-601-9749    

PR Contact:

Monique Merhige

President

Infusion Direct Marketing, Inc.

monique@infusiondirect.com

Tel: 772-380-4845

Share article on social media or email:

Healthcare Management Solutions, LLC (HMS) Awarded Contract by Missouri Department of Health & Senior Services to Conduct Surveys


News Image

We are honored to be selected by the Missouri Department of Health & Senior Services to conduct these surveys. All Missouri residents deserve quality long-term care. We appreciate this opportunity to help protect vulnerable populations across the state. – Leah Heimbach, President of HMS

The Missouri Department of Health & Senior Services (DHSS) has awarded Healthcare Management Solutions, LLC (HMS) a contract to support its work by providing qualified surveyors to conduct long-term care facility recertification and complaint surveys.

“We are honored to be selected by the Missouri Department of Health & Senior Services to conduct these surveys,” said Leah Heimbach, President of HMS. “All Missouri residents deserve quality long-term care. We appreciate this opportunity to help protect vulnerable populations across the state.”

HMS will be conducting comprehensive reviews of everything from infection control and nursing services, medication dispensing, diet and exercise, patients’ rights, the physical environment and much more, including record reviews, resident interviews, kitchen inspections, and staff observation.

This project is eighty-three percent (83%) funded by the Centers for Medicare and Medicaid Services (CMS) of the U.S. Department of Health and Human Services (HHS) under the Title XVIII Survey and Certification grant. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by CMS, HHS or the U.S. Government.

About Healthcare Management Solutions, LLC

HMS protects vulnerable populations and veterans. We blend our unique healthcare and technology expertise to create bold, yet cost-effective solutions that federal and state agencies and our private-sector partners need to make sure your loved ones get the best possible care in nursing homes and other healthcare settings, no matter where in America they live.

Share article on social media or email:

Arriello appoints distinguished regulatory expert, Pete Embley, as Chief Regulatory Officer


Pete Embley

Pete Embley

Regulatory is a key function within in the pharma and biotech world, so it feels right to join a business that positions this as a pivotal part of the business.

Arriello, a leading provider of integrated Regulatory Affairs, Pharmacovigilance and Auditing & QA solutions and services, has appointed respected regulatory expert Pete Embley as Chief Regulatory Officer, signalling the company’s commitment to growing its pre-approval service line.

The move comes as soaring biotech activity in both Europe and the US is driving strong demand for an integrated, high-touch service offering Regulatory, Quality Assurance (QA) and Pharmacovigilance (PV). The catalyst is the rise in young and ambitious biopharma companies which are seeking end-to-end support from early development of new technologies, including Advanced Therapy Medicinal Products (ATMPs), and market expansion, to longer-term safety monitoring and risk management including continuous quality management and assurance right along the supply chain.

Pete, who joined Arriello in September and is based in Oxford in the UK, is the company’s first Chief Regulatory Officer. His appointment is another important milestone for the fast-growing service provider.

Commenting on his ambitions for the company, he said, “The increase in accelerated regulatory development pathways for personalised and rare disease therapies demands an integrated Regulatory, Pharmacovigilance and QA service offering from a much earlier stage. Accelerated pathways trigger an earlier and more intensive engagement with Regulatory agencies. Arriello recognises this and my new role will reflect our strong commitment to fulfilling these combined needs with an optimised cross-discipline service from the earliest point of need.”

Pete is a highly experienced consultant, having worked in the pharmaceuticals industry for more than two decades, spanning Regulatory positions with increasing responsibilities at Norton Healthcare, GlaxoSmithKline, IVAX, Ranbaxy, Chugai Pharma Europe, PPD, Voisin Life Sciences Consulting and, most recently, Bionical Emas.

Pete has known Arriello since the company’s inception, having previously worked with the co-founders Alan White and Anna Lukyanova.

He said, “When Alan and Anna formed Arriello, the company was focused primarily on the maturing PV industry. I have followed the company’s evolution very closely and it got to the point where I just couldn’t turn down the opportunity to join this dynamic and very successful business, whose value is inextricably linked to the calibre of its people.”

He added, “My role is to develop the Pre-Approval service line, and complement Arriello’s well-established post-approval services. This expansion couldn’t be better timed, and I couldn’t be more excited at the opportunity ahead of us.

“Regulatory is a key function within in the pharma and biotech world, so it feels right to join a business that positions this as a pivotal part of the business. It’s this clear definition which means we can give our clients the optimum support they need in getting to market and maintaining compliance.”

Pete will be growing the full-service client base, with ambitions to further enhance the wraparound support for ambitious biotechs, to include help with Commercialisation and Market Access.

Welcoming him to Arriello, CEO and co-founder Alan White said, “Anna and I, and indeed the whole of the Arriello family, are delighted that Pete has come on board at this exciting time. His deep Regulatory expertise and broad experience will be instrumental in expanding our offering to fulfil more of our clients’ needs as ambitions around therapies for rare diseases soar. Our clients couldn’t be in better hands.

Anna Lukyanova, COO, and co-founder, said, “Pete’s appointment is important and very timely, and we welcome him warmly. Now more than ever, Arriello is in a position both to help homegrown European biopharma companies progress their developments and provide a gateway into Europe for US biotechs. Today, we can provide comprehensive support from a very early stage – across Regulatory strategy to get into clinical trials; providing the scientific advice and clinical trial applications support, managing the engagement with the CRO; and then helping with the Commercialisation and Market Access pathway. And that’s all while taking care of the product’s safety profile, as well as the evolving quality management system as the scope of our clients’ activities – and their data – grows.”

She continued, “We’re also thrilled at what this means for our own people. Growing our Pre-Approval services will provide a chance for existing teams to further develop their Regulatory skills and knowledge, making Arriello an even more attractive place to work.”

Over the last year, Arriello has made a number of strategic senior appointments, including Kieran O’Donnell as VP of Drug Safety and Principal Consultant for Pharmacovigilance, and Helen Lowe as Auditing & QA Director.

About Arriello

Arriello has been providing risk management and compliance services to the life sciences sector since 2008. These services include market consultancy, global regulatory affairs strategy and implementation, full and local pharmacovigilance solutions, clinical drug safety, and quality and compliance auditing systems.

Headquartered in Ireland, with European operations in Central Europe, our technical team has a combined experience of over 130 years working across the EU, US, LATAM, MENA, CIS, APAC regions and South Africa.

More at http://www.arriello.com and @Arriello

Media contact:

Carina Birt

Sarum Life Sciences for Arriello

carina@sarumlifesciences.com

+44 7970 006624

Medical Aesthetics Expert Dr. Susan B. Fox Joins Exclusive Haute Beauty Network


News Image

Dr. Fox and her office have won awards for vein care, tattoo removal, being a top medical spa and laser hair removal.

At Fox Vein & Laser Experts, we specialize in the diagnosis and treatment of venous disease, including varicose veins, leg pain and swelling, ulcer care, venous insufficiency, deep vein thrombosis, pulmonary embolism, and blood clotting disorders. We have a highly skilled vascular lab with a registered physician vascular interpreter. Our medical team has decades of experience treating venous disease, and Dr. Susan Fox and her team have successfully performed tens of thousands of vein procedures. They have developed their own vein procedures and techniques and are recognized vein experts.

Dr. Susan Fox has been featured on American and Latin American television programs as a vein expert. She has written several articles and lectured nationally on the treatment of veins. We offer the newest and best minimally invasive vein procedures including; Endovenous laser ablation, ClariVein®, Venclose, Ambulatory phlebectomies, and ultrasound-guided Varithena, foam, and traditional sclerotherapy. Dr. Susan Fox was the first physician in Cleveland to perform endovenous laser ablation and one of the first nationally. She has performed thousands of successful endovenous laser ablations for over a decade. She was the first in Broward County, Florida, to Perform the ClariVein® procedure and one of the first in the US to offer this treatment option. We are a training facility for vein procedures, and Dr. Susan Fox has successfully taught physicians and medical personnel about treating venous disease for over a decade. Dr. Susan Fox and her staff have decades of experience and thousands of happy patients.

Over the decades, Dr. Fox expanded and began offering more and more cosmetic procedures as part of the practice. These include injectable fillers and biostimulators, toxins, microneedling with radio frequency, hair regrowth, peels, facials, body contouring, hand rejuvenation, and so much more. Dr. Fox and her office have won awards for vein care, tattoo removal, being a top medical spa and laser hair removal. They offer cutting-edge devices and stay at the top of their field.

Learn more about Dr. Susan B. Fox by visiting: https://hauteliving.com/hautebeauty/member/dr-susan-b-fox/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Share article on social media or email:

Memorial Regional Hospital Recognized for the Capabilities and Outcomes of its ECMO Program


Memorial Regional Hospital’s ECMO program has been designated a “Gold Level Center of Excellence” by the Extracorporeal Life Support Organization (ELSO)

“Memorial Cardiac and Vascular Institute teams are focused on providing patients the very best critical care services, integrating advanced life support equipment and patient care.” — Dr. I-wen Wang, chief of Memorial’s Adult Heart Transplant & Mechanical Circulatory Support Program

Memorial Regional Hospital has been recognized by Extracorporeal Life Support Organization (ELSO) as a “Designated Gold Level Center of Excellence” for its extracorporeal membrane oxygenation (ECMO) program. The Memorial Healthcare System facility is one of only four adult hospitals in Florida to earn the recognition from the international society and the only program south of Orlando. The Center of Excellence designation requires re-application every 3 years, with this being the second consecutive Gold award for Memorial.

ECMO is an advanced therapy that uses a machine to temporarily replace the function of the heart and lungs of critically-ill patients recovering from severe lung damage, cardiogenic shock or heart failure. Blood is pumped and oxygenated outside of the body, and then returned to the body, allowing the patient’s heart and/or lungs to rest.

Designated Centers of Excellence are experienced in-patient care providers with established policies, procedures, training, education and community leadership. Centers must incorporate highly developed quality initiatives and continuously review processes within their program. Outcome reviews must be demonstrated as an integral component of their organization.

“Our Memorial Cardiac & Vascular Institute teams are focused on providing patients the very best critical care services, integrating advanced life support equipment and patient care,” said Dr. I-wen Wang, chief of Memorial Healthcare System’s Adult Heart Transplant & Mechanical Circulatory Support Program. “Being recognized as a gold level Center of Excellence at Memorial Regional reflects the dedication to advancing healthcare that we continuously strive to achieve daily.”

Memorial’s ECMO program is made up of a multi-disciplinary team of critical care, cardiac surgery, heart failure, and transplant surgery specialists who work together to support patients. It was the first provider in South Florida to offer mobile ECMO services, which provide safe hospital-to-hospital transfers of ECMO patients under the care and supervision of a specially-trained transport team.

ELSO is an international, nonprofit consortium of healthcare institutions, researchers, providers, and industry partners. It provides support to those delivering extracorporeal life support through continuing education, guidelines, original research, publications, and a comprehensive registry of extracorporeal membrane oxygenation (ECMO) patient data.

The Memorial Cardiac & Vascular Institute is a cardiovascular care leader, offering a wide array of services dedicated to the prevention, detection, and treatment of cardiovascular disease. Its multi-disciplinary specialists collaborate using sophisticated diagnostic equipment and facilities. Cardiovascular care outcomes are regularly reviewed by physician-review panels and nurses to ensure quality assurance that utilizes computerized data collection.

For more information on total heart care, you can visit them at mhs.net/services/cardiac-vascular.

Share article on social media or email:

Nash Dental Care In Temecula, CA Is Now Ethos Advanced Dental Care


Ethos Advanced Dental Care in Temecula, CA

Ethos Advanced Dental Care

“I am excited to continue to bring advanced dental care to my patients in Temecula. Even though we have rebranded and will now be known as Ethos Advanced Dental Care, we will continue to provide exceptional care in a comfortable and caring environment, along with my associate Dr. Fernando Vargas.”

Dr. Guy Nash, the founder and owner of Nash Dental Care in Temecula, has announced his retirement after practicing dentistry for 35 years. Dr. Jeremy Sewell, his long-time associate has acquired the practice. Nash Dental Care had been recently rebranded to Ethos Advanced Dental Care. The practice will continue to operate at the current location, 29740 Rancho California Road, Suite #100, in Temecula. Patients will receive the same state-of-the-art and compassionate care that was delivered under the guidance of Dr. Nash. “I’m very grateful Dr. Sewell can step into this ownership role, which makes the transition into retirement a possibility. Dr. Sewell and I share the same compassion, credentials, philosophy, and commitment to dental excellence,” said Dr. Nash.

Dr. Nash opened Nash Dental Care in Temecula, CA in 1988, with the goal of bringing the Temecula Valley the latest and highest level of care in family, cosmetic, sedation and implant dentistry. Dr. Nash will retire at the end of 2022 to spend more time with his wife, two children and three beautiful grandchildren. “I greatly appreciate the opportunity to have served my patients throughout the Temecula valley for over 3 decades. I will truly miss interacting with my patients and the artistry of my profession,” said Dr. Nash.

Dr. Sewell has been practicing dentistry since 2009, after receiving his Doctor of Dental Medicine from the University of Nevada Las Vegas. He joined Nash Dental Care in Temecula, CA in 2010. He chose dentistry as a career because his dentist, as a child, changed his life through giving him a healthy and confident smile. In addition, he loves working with people through health care, and giving them the happy, healthy smile, they deserve. Dr. Sewell is excited to continue to bring his passion for dentistry to the patients of Ethos Advanced Dental Care.

“I am excited to continue to bring advanced dental care to my patients in Temecula. Even though we have rebranded and will now be known as Ethos Advanced Dental Care, we will continue to provide exceptional care in a comfortable and caring environment. Along with my associate Dr. Fernando Vargas, we will be keeping the same team members that have been essential in creating the experience patients have come to expect,” commented Dr. Sewell.

Dr. Nash will formally retire on December 31, 2022.

To schedule an appointment at Ethos Advanced Dental Care, please visit EthosAdvancedDental.com or call 951.699.0700.

Share article on social media or email:

Advancing Research with Humanized Models and AI, Upcoming Webinar Hosted by Xtalks


It has become increasingly essential for researchers, biotechs and pharmaceutical companies developing rare disease therapies to implement AI tools that get results both quickly and cost-effectively — vastly reducing time to clinical trials.

The discovery and development of orphan drugs and gene therapies for rare diseases face many challenges, including: insufficient knowledge regarding the underlying disease mechanisms, the lack of clinically relevant humanized animal disease models, insufficient AAV vector productivity and targeted delivery in gene therapy development and more.

In light of the challenges faced with orphan drug development, there has been growing interest in leveraging bioinformatics and artificial intelligence (AI) tools for accelerating drug discovery. It has become increasingly essential for researchers, biotechs and pharmaceutical companies developing rare disease therapies to implement AI tools that get results both quickly and cost-effectively — vastly reducing time to clinical trials.

The Rare Disease Data Center (RDDC) provides interfaces for the interactive visualization and exploration of biomedical data alongside several gene diagnosis tools based on the sophisticated AI and machine learning models. The RDDC integrates all reported rare disease data and information, including: epidemiological data, disease-related gene profile, variants, phenotypes, drug developmental outlines and disease-associated mouse models.

Register for the webinar now and join Dr. Kugeng (KG) Huo, for a discussion on how to use the Rare Diseases Data Center (RDDC) resources and Cyagen’s one-stop CRO platform to accelerate the R&D of effective gene therapies for rare diseases.

Join Kugeng (KG) Huo, PhD, Senior Scientist, Cyagen Biosciences, for the live webinar on Friday, December 9, 2022, at 11am EST (5pm CET/EU-Central).

For more information, or to register for this event, visit Gene Therapies and Rare Diseases: Advancing Research with Humanized Models and AI.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email: